Grenfell Prosecution Recommendations Signal Potential Financial Repercussions for Construction and Insurance Sectors
Paul Tudor Jones Dismisses Possibility of Fed Rate Cuts Under Warsh Leadership
Jim Cramer Investigates Adobe ADBE What It Means for Investors
Analyst Report Highlights TJX Companies Resilience in OffPrice Retail Sector
Amtrak Ridership Soars to Records Infrastructure Under Spotlight for 2026 World Cup
Meta Settles Key Social Media Addiction Lawsuit Potentially Affecting Over 1200 Similar Claims
Dave Busters Entertainment Inc PLAY Q1 2026 Earnings Massive EPS Miss Masks Surprising Stock Rally
BFH Q1 2026 Earnings Beats Estimates with EPS Surprise of 3383
SNFCA Q4 2025 Earnings Earnings per share of 053 reported stock edges lower
Vitesse Energy VTS Q1 2026 Earnings EPS Misses Estimates Significantly as Stock Edges Lower
Gulf Resources Inc Q3 2023 Earnings Deepening Loss Amidst Opaque Reporting
Vistance Networks Inc VISN Q1 2026 Earnings EPS Surges Past Estimates with 7094 Surprise
GrowGeneration Corp GRWG Gains 170 as Shares Test Key Resistance Levels
Willis Lease Finance Holds Near Resistance Amid Low Volatility WLFC
Voya Infrastructure Industrials and Materials Fund IDE Faces Selling Pressure as Shares Slide Over 1
cbdMD Inc YCBD Slips 2 as Stock Tests Key Support Near 070
Leapfrog Acquisition Corporation LFAC Flatlining Near Trust Value as Market Awaits Catalysts
Morgan Stanley Reaffirms Equal Weight Rating on Camden Property Trust CPT
ADAMZ Q1 2026 Earnings Preferred Stock Delivers Strong EPS Beat Despite Modest Share Decline
Nektar Therapeutics NKTR Navigates a 287 Decline as Key Support Levels Come Into Focus
Savara Inc SVRA Q1 2026 Earnings WiderThanExpected Loss as PreRevenue Biotech Advances Pipeline
DBD Q1 2026 Earnings EPS Beats Estimates Shares Rise on Profitability Strength
Chubb Limited CB Q1 2026 Earnings Slight EPS Beat Amid Modest Stock Pullback
NGNE Q1 2026 Earnings Earnings Miss Estimates as Pipeline Progress Offsets Financial Headwinds
Woodward Inc WWD Q1 2026 Earnings EPS Beats Estimates by 782 as Stock Edges Lower
Instil Bio Q1 2026 Earnings EPS Miss as DevelopmentStage Company Reports No Revenue Stock Edges Up
AGO Q1 2026 Earnings Strong Underwriting Performance Drives Major EPS Surprise Yet Shares Slip